We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos and MorphoSys initiate Phase 1 study

News   Apr 08, 2016

 
Galapagos and MorphoSys initiate Phase 1 study
 
 
 

RELATED ARTICLES

Antibodies Stabilize Plaque in Arteries

News

An unexpected role for type IgG antibodies has been identified, after a study in mice showed that the antibodies stabilize the plaque that accumulates on the artery walls, reducing the risk of rupture and blood clot.

READ MORE

Zika Study May "Supercharge" Vaccine Research

News

Scientists looking at the genetics of Zika virus have found a way to fast-track research which could lead to new vaccines.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE